Andreas Busch
Chief Innovation Officer at Absci Corp (ABSI) since March 2022
Andreas Busch has filed 16 insider reports with the SEC since December 2021, as chief Innovation Officer at Absci Corp (ABSI) and officer at Cyclerion Therapeutics, Inc. (KRSA). In the last 12 months Andreas Busch bought $229K of stock on the open market. In the latest filing, on March 16, 2026, Andreas Busch bought 100,000 shares of Absci Corp (ABSI) for $229K at an average of $2.29.
- Filings
- 16
- Companies
- 2
- Bought on market
- $381K
- Sold on market
- None
Companies where Andreas Busch is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Innovation Officersince March 2022 | 421,446 | $381K | $2.54 | $7.51+196% | Mar 16, 2026 | ||
| Officer | $37.56 | Jan 24, 2022 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Mar 12, 2026+$229KABSIChief Innovation Officer Busch Andreas bought $229,000 worth of shares (100,000 units at $2.29), increasing direct ownership by 31% to 421,446 unitsForm 4Open-market purchase
- Mar 3, 2026ABSIChief Innovation Officer Busch Andreas covered exercise/tax liability with 1,257 shares, decreasing direct ownership by 0.39% to 321,446 unitsForm 4Shares withheld for taxes or exercise price
- Feb 3, 2026ABSIChief Innovation Officer Busch Andreas covered exercise/tax liability with 1,469 shares, decreasing direct ownership by 0.45% to 322,703 unitsForm 4Shares withheld for taxes or exercise price
- Oct 14, 2025ABSIChief Innovation Officer Busch Andreas covered exercise/tax liability with 3,092 shares, decreasing direct ownership by 0.94% to 324,172 unitsForm 4Shares withheld for taxes or exercise price
- Jul 28, 2025+$152KABSIChief Innovation Officer Busch Andreas bought $152,000 worth of shares (50,000 units at $3.04), increasing direct ownership by 18% to 327,264 unitsForm 4Open-market purchase
- Mar 3, 2025ABSIChief Innovation Officer Busch Andreas was granted 23,700 shares, increasing direct ownership by 9% to 277,264 unitsForm 4Grant or award
- Feb 1, 2025ABSIChief Innovation Officer Busch Andreas covered exercise/tax liability with 1,469 shares, decreasing direct ownership by 0.58% to 253,564 unitsForm 4Shares withheld for taxes or exercise price
- Oct 12, 2024ABSIChief Innovation Officer Busch Andreas covered exercise/tax liability with 3,092 shares, decreasing direct ownership by 1% to 255,033 unitsForm 4Shares withheld for taxes or exercise price
- Feb 1, 2024ABSIBusch Andreas was granted 83,125 shares, increasing direct ownership by 48% to 258,125 unitsForm 4Grant or award
- Oct 12, 2023ABSIBusch Andreas was granted 175,000 sharesForm 4Grant or award
- Oct 3, 2022ABSISEC Form 4 filed by Busch AndreasForm 4Grant or award
- Jun 8, 2022ABSISEC Form 4 filed by Busch AndreasForm 4Grant or award
- Mar 17, 2022ABSISEC Form 4 filed by Busch AndreasForm 4Grant or award
- Mar 17, 2022ABSIAndreas Busch became an insiderForm 3New insider
- Jan 20, 2022KRSASEC Form 4 filed by Busch AndreasForm 4Grant or award
- Dec 9, 2021KRSASEC Form 4 filed by Busch AndreasForm 4Grant or award
Compare Andreas Busch with
- Andreas Busch vs Michelle Patricia Pernice1 shared
- Andreas Busch vs Nimish P Shah1 shared
- Andreas Busch vs Andrew Gottesdiener1 shared
- Andreas Busch vs Jonathan Violin1 shared
- Andreas Busch vs Heidi Henson1 shared
- Andreas Busch vs Mark J. Vignola1 shared
Other insiders at the same companies
- Rhonda M. ChickoKRSA
- Michelle Patricia PerniceKRSA
- Fairmount Funds Management LLCKRSA
- Nimish P ShahKRSA
- Andrew GottesdienerKRSA
- Jonathan ViolinKRSA
- Matthew James LeoniKRSA
- Heidi HensonKRSA
- Mark J. VignolaKRSA
- Zachariah JonassonABSI
- Regina Margaret GraulKRSA
- Ransi Mudalinayake SomaratneABSI
- Peter M HechtKRSA
- Mary T SzelaABSI
- Sean McClainABSI
- Karen K McginnisABSI
Questions about Andreas Busch
- What is Andreas Busch's role at Absci Corp?
- Andreas Busch reports to the SEC as chief Innovation Officer at Absci Corp (ABSI), according to the latest filing on March 16, 2026. Andreas Busch has also filed as officer at Cyclerion Therapeutics, Inc. (KRSA).
- How many shares does Andreas Busch own?
- After the latest filing that states it, Andreas Busch directly owned 421,446 shares of Absci Corp (ABSI). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Andreas Busch bought or sold stock recently?
- The most recent open-market purchase was on March 12, 2026: bought 100,000 shares of Absci Corp (ABSI) for $229K at an average of $2.29.
- How do I get alerts when Andreas Busch files?
- Follow Andreas Busch on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Andreas Busch (SEC CIK 0001775029). Totals count each trade once, skipping amendments whose original is on file, from Dec 10, 2021 on. View on SEC EDGAR · Get this as JSON